Emerson Yu-sheng Chen, Alyson Haslam, Vinay K. Prasad
Abstract
Open-access reader
This retrospective review assesses the frequency of surrogate measures used for the first time vs subsequent times in a cancer setting and the surrogate’s strength of correlation with patient-centered outcomes.
OpenAlex reports 124 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This retrospective review assesses the frequency of surrogate measures used for the first time vs subsequent times in a cancer setting and the surrogate’s strength of correlation with patient-centered outcomes.
Key concepts: Medicine, Surrogate endpoint, Cancer drugs, Retrospective cohort study, Cancer, Drug approval, Drug, Medical physics